InMed Pharmaceuticals Inc（INM）價格預測INMInMed Pharmaceuticals Inc

Alphio's INM stock price prediction model matches the current InMed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.54 (+7.73%). The 1-week path is $16.40 (+13.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

InMed Pharmaceuticals, now Mentari Therapeutics, is a good buy right now due to its recent merger which is expected to enhance market competitiveness. The stock has shown a 9.20% increase yesterday, indicating positive momentum, and the forward P/E is currently at 0, suggesting potential for future earnings growth. However, the company reported a net income loss of -5,839,392 USD in Q4 2026, which remains a risk factor.

InMed Pharmaceuticals Inc (INM) last closed at $14.4250002, gaining +9.20%. These facts feed the 1-day and 1-week INM price prediction above.